The US Food and Drug Administration (FDA) has issued its first marketing authorisations for e-cigarette products, following the rejection of millions of others.
The authorisations cover RJ Reynolds’s Vuse Solo device and two 4.8% nicotine tobacco-flavoured pods, which the FDA said exposed users to reduced risk compared to combustible cigarettes. While the authorisations allow the products to be sold legally in the US, the FDA did impose limits on digital, TV and radio advertising.
...
Need help?
Contact a sales representative right now and don’t wait
“ First PMTA success for Reynolds’s Vuse products – but tobacco flavours only ”
Buy report request information:
“ First PMTA success for Reynolds’s Vuse products – but tobacco flavours only ”
The US Food and Drug Administration (FDA) has issued its first marketing authorisations for e-cigarette products, following the rejection of millions of others.
The authorisations cover RJ Reynolds’s Vuse Solo device and two 4.8% nicotine tobacco-flavoured pods, which the FDA said exposed users to reduced risk compared to combustible cigarettes. While the authorisations allow the products to be sold legally in the US, the FDA did impose limits on digital, TV and radio advertising.
Get access to premium content that is normally only available for subscribers.
For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the ECigIntelligence team.
LATEST ALERTS
